Email to a Colleague
Medscape Conference Coverage, based on selected sessions at the:
European Meeting on Hypertension
June 12 - 16, 2006, Madrid, Spain

This activity is not sanctioned by, nor a part of, Sixteenth European Meeting on Hypertension.


Topic Overviews
Strengthening and Updating European Guidelines for the Management of Arterial Hypertension
As the Writing Group from ASH moves toward consideration of overall risk, in line with the established European hypertension guidelines, the ESH/ESC are actively updating their guidelines in light of new data.
JEWEL Program: Optimizing Treatment for Patients With Hypertension and Additional Cardiovascular Risk Factors
Can the efficacy of targeting multiple CVD risk factors with a fixed-dose, single pill combination therapy provide sufficient protection to justify the added convenience (and presumably adherence) of this approach?
Extended Benefits of Atorvastatin and Support for Use of Doxazosin GITS in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Blood Pressure Lowering Arm
Further analysis of the landmark ASCOT trial results continues to yield insights into how to treat a typical hypertensive patient who often has concomitant hyperlipidemic risks.
Meta-Analyses: The Effects of Statins on Blood Pressure
An ongoing question is whether, in addition to their effects on serum lipid levels, statins have a purely antihypertensive effect -- as investigated in 2 meta-analyses presented at the 2006 ESH meeting.
Renin Inhibitor Aliskiren in Combination With ACE Inhibitor in Diabetic Patients With Hypertension
The first-in-Europe findings from the first-in-class new renin inhibitor, aliskiren, continue the promise of the earlier results.

 
Legal Disclaimer
The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the European Meeting on Hypertension. These materials and the related activity are not sanctioned by the European Meeting on Hypertension or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2006 Medscape.

 


WebMD

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.